|
Transplantation
Citations 381-390 of 1455 total displayed.
|
Past content
(since Jan 1997):
|
Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency
- José A. Borghans, Robbert G. Bredius, Mette D. Hazenberg, Helene Roelofs, Els C. Jol-van der Zijde, Jeroen Heidt, Sigrid A. Otto, Taco W. Kuijpers, Willem E. Fibbe, Jaak M. Vossen, Frank Miedema, and Maarten J. van Tol
Blood 2006; 108: 763-769.
[Abstract]
[Full text]
[PDF]
Lethal hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II
- Anselm Enders, Barbara Zieger, Klaus Schwarz, Ayami Yoshimi, Carsten Speckmann, Eva-Maria Knoepfle, Udo Kontny, Christoph Müller, Alan Nurden, Jan Rohr, Matthias Henschen, Ulrich Pannicke, Charlotte Niemeyer, Paquita Nurden, and Stephan Ehl
Blood 2006; 108: 81-87.
[Abstract]
[Full text]
[PDF]
Allogeneic T cells induce rapid CD34+ cell differentiation into CD11c+CD86+ cells with direct and indirect antigen-presenting function
- Javaneh Abbasian, Dolores Mahmud, Nadim Mahmud, Sandeep Chunduri, Hiroto Araki, Pavan Reddy, Ronald Hoffman, Mario Arpinati, James L. M. Ferrara, and Damiano Rondelli
Blood 2006; 108: 203-208.
[Abstract]
[Full text]
[PDF]
Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan
- Sung-Won Kim, Tetsuya E. Tanimoto, Noriyuki Hirabayashi, Seiichi Goto, Masahiro Kami, Satoshi Yoshioka, Toshiki Uchida, Kenji Kishi, Yuji Tanaka, Akio Kohno, Masaharu Kasai, Masakazu Higuchi, Masanobu Kasai, Shin-ichiro Mori, Takahiro Fukuda, Koji Izutsu, Hiroshi Sao, Takayuki Ishikawa, Tatsuo Ichinohe, Kengo Takeuchi, Kinuko Tajima, Ryuji Tanosaki, Mine Harada, Shuichi Taniguchi, Kensei Tobinai, Tomomitsu Hotta, and Yoichi Takaue
Blood 2006; 108: 382-389.
[Abstract]
[Full text]
[PDF]
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production
- Robert Zeiser, Vu H. Nguyen, Andreas Beilhack, Martin Buess, Stephan Schulz, Jeanette Baker, Christopher H. Contag, and Robert S. Negrin
Blood 2006; 108: 390-399.
[Abstract]
[Full text]
[PDF]
Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer
- Elisabeth H. Slager, M. Willy Honders, Edith D. van der Meijden, Simone A. P. van Luxemburg-Heijs, Freke M. Kloosterboer, Michel G. D. Kester, Inge Jedema, W. A. Erik Marijt, M. Ron Schaafsma, Roel Willemze, and J. H. Frederik Falkenburg
Blood 2006; 107: 4954-4960.
[Abstract]
[Full text]
[PDF]
Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research
- Mary Eapen, Elizabeth Raetz, Mei-Jie Zhang, Catherine Muehlenbein, Meenakshi Devidas, Thomas Abshire, Amy Billett, Alan Homans, Bruce Camitta, William L. Carroll, and Stella M. Davies, for the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research
Blood 2006; 107: 4961-4967.
[Abstract]
[Full text]
[PDF]
Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemia
- Carol Moreno, Neus Villamor, Dolors Colomer, Jordi Esteve, Eva Giné, Ana Muntañola, Elias Campo, Francesc Bosch, and Emili Montserrat
Blood 2006; 107: 4563-4569.
[Abstract]
[Full text]
[PDF]
Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy
- Jaspal Kaeda, Derville O'Shea, Richard M. Szydlo, Eduardo Olavarria, Francesco Dazzi, David Marin, Susan Saunders, Jamshid S. Khorashad, Nicholas C. P. Cross, John M. Goldman, and Jane F. Apperley
Blood 2006; 107: 4171-4176.
[Abstract]
[Full text]
[PDF]
Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti–thymocyte globulin
- Maria Teresa Van Lint, Giuseppe Milone, Salvatore Leotta, Cornelio Uderzo, Rosanna Scimè, Sandro Dallorso, Anna Locasciulli, Stefano Guidi, Nicola Mordini, Simona Sica, Laura Cudillo, Franca Fagioli, Carmine Selleri, Barbara Bruno, William Arcese, and Andrea Bacigalupo, for the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
Blood 2006; 107: 4177-4181.
[Abstract]
[Full text]
[PDF]
|
|
